Quality of life and fatigue in Hodgkin's lymphoma patients

Zsófia Miltényi, Ferenc Magyari, Zsófia Simon, A. Illés

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Aims and background. Quality of life and survival of patients with malignant diseases are improving thanks to the development in diagnostics and therapy. Methods. We determined the quality of life and frequency and severity of fatigue with an EORTC QLQ-C30 questionnaire in 168 Hodgkin's lymphoma patients (85 women, 83 men). We scored all functional and symptom scales in cured patients (who were in complete remission for at least 10 years; mean period of survival after the treatment(s) was 16.61 years) and in those who suffered from late complications. Results. The global health status score (QL2) was significantly lower in patients who had late complications (mean QL2, 45.53) than in patients with no complications (mean QL2, 67.57, P

Original languageEnglish
Pages (from-to)594-600
Number of pages7
JournalTumori
Volume96
Issue number4
Publication statusPublished - 2010

Fingerprint

Hodgkin Disease
Fatigue
Quality of Life
Survival
Health Status
Therapeutics

Keywords

  • Fatigue
  • Hodgkin's lymphoma
  • Quality of life
  • Survival

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

Miltényi, Z., Magyari, F., Simon, Z., & Illés, A. (2010). Quality of life and fatigue in Hodgkin's lymphoma patients. Tumori, 96(4), 594-600.

Quality of life and fatigue in Hodgkin's lymphoma patients. / Miltényi, Zsófia; Magyari, Ferenc; Simon, Zsófia; Illés, A.

In: Tumori, Vol. 96, No. 4, 2010, p. 594-600.

Research output: Contribution to journalArticle

Miltényi, Z, Magyari, F, Simon, Z & Illés, A 2010, 'Quality of life and fatigue in Hodgkin's lymphoma patients', Tumori, vol. 96, no. 4, pp. 594-600.
Miltényi Z, Magyari F, Simon Z, Illés A. Quality of life and fatigue in Hodgkin's lymphoma patients. Tumori. 2010;96(4):594-600.
Miltényi, Zsófia ; Magyari, Ferenc ; Simon, Zsófia ; Illés, A. / Quality of life and fatigue in Hodgkin's lymphoma patients. In: Tumori. 2010 ; Vol. 96, No. 4. pp. 594-600.
@article{7188940ace5c49c7b86067b0d1f29127,
title = "Quality of life and fatigue in Hodgkin's lymphoma patients",
abstract = "Aims and background. Quality of life and survival of patients with malignant diseases are improving thanks to the development in diagnostics and therapy. Methods. We determined the quality of life and frequency and severity of fatigue with an EORTC QLQ-C30 questionnaire in 168 Hodgkin's lymphoma patients (85 women, 83 men). We scored all functional and symptom scales in cured patients (who were in complete remission for at least 10 years; mean period of survival after the treatment(s) was 16.61 years) and in those who suffered from late complications. Results. The global health status score (QL2) was significantly lower in patients who had late complications (mean QL2, 45.53) than in patients with no complications (mean QL2, 67.57, P",
keywords = "Fatigue, Hodgkin's lymphoma, Quality of life, Survival",
author = "Zs{\'o}fia Milt{\'e}nyi and Ferenc Magyari and Zs{\'o}fia Simon and A. Ill{\'e}s",
year = "2010",
language = "English",
volume = "96",
pages = "594--600",
journal = "Tumori",
issn = "0300-8916",
publisher = "Wichtig Publishing",
number = "4",

}

TY - JOUR

T1 - Quality of life and fatigue in Hodgkin's lymphoma patients

AU - Miltényi, Zsófia

AU - Magyari, Ferenc

AU - Simon, Zsófia

AU - Illés, A.

PY - 2010

Y1 - 2010

N2 - Aims and background. Quality of life and survival of patients with malignant diseases are improving thanks to the development in diagnostics and therapy. Methods. We determined the quality of life and frequency and severity of fatigue with an EORTC QLQ-C30 questionnaire in 168 Hodgkin's lymphoma patients (85 women, 83 men). We scored all functional and symptom scales in cured patients (who were in complete remission for at least 10 years; mean period of survival after the treatment(s) was 16.61 years) and in those who suffered from late complications. Results. The global health status score (QL2) was significantly lower in patients who had late complications (mean QL2, 45.53) than in patients with no complications (mean QL2, 67.57, P

AB - Aims and background. Quality of life and survival of patients with malignant diseases are improving thanks to the development in diagnostics and therapy. Methods. We determined the quality of life and frequency and severity of fatigue with an EORTC QLQ-C30 questionnaire in 168 Hodgkin's lymphoma patients (85 women, 83 men). We scored all functional and symptom scales in cured patients (who were in complete remission for at least 10 years; mean period of survival after the treatment(s) was 16.61 years) and in those who suffered from late complications. Results. The global health status score (QL2) was significantly lower in patients who had late complications (mean QL2, 45.53) than in patients with no complications (mean QL2, 67.57, P

KW - Fatigue

KW - Hodgkin's lymphoma

KW - Quality of life

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=77957201707&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957201707&partnerID=8YFLogxK

M3 - Article

C2 - 20968140

AN - SCOPUS:77957201707

VL - 96

SP - 594

EP - 600

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 4

ER -